Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes Mellitus

Schwartz, Sherwyn; Raskin, Philip; Fonseca, Vivian; F. Graveline, Jane

doi:10.1056/nejm199803263381302

Public

Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes Mellitus

Published in New England Journal of Medicine • Mar 26, 1998

Authors:

Sherwyn Schwartz

Philip Raskin

Vivian Fonseca

Abstract

BACKGROUND: Troglitazone is a new oral antidiabetic drug that increases the sensitivity of peripheral tissues to insulin. It may therefore increase the efficacy of exogenous insulin in patients with insulin-resistant diabetes mellitus. METHODS: We studied the effect of troglitazone or placebo in 350...

Subject

Troglitazone

Medicine

Insulin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!